Hyperfine (NASDAQ:HYPR) Trading Down 1.4% - Time to Sell?

Key Points

• Hyperfine's shares (NASDAQ:HYPR) fell by 1.4% during mid-day trading, with the stock last trading at $1.45, down from a previous close of $1.47.
• Analysts have mixed views on Hyperfine, with Lake Street Capital upgrading their price target to $2.00 while Wells Fargo raised it to $0.85, leading to an average price target of $1.28.
• The company's recent quarterly earnings report showed a negative EPS of ($0.12) and a revenue of $2.70 million, which was below the consensus estimate of $3.00 million.

Shares of Hyperfine, Inc. (NASDAQ:HYPR - Get Free Report) were down 1.4% during mid-day trading on Tuesday . The company traded as low as $1.42 and last traded at $1.45. Approximately 109,953 shares were traded during trading, a decline of 68% from the average daily volume of 343,539 shares. The stock had previously closed at $1.47.

Analyst Upgrades and Downgrades

Several brokerages have commented on HYPR. Lake Street Capital upped their price objective on Hyperfine from $1.50 to $2.00 and gave the company a "buy" rating in a research report on Thursday, August 14th. B. Riley restated a "buy" rating on shares of Hyperfine in a report on Tuesday, June 3rd. Finally, Wells Fargo & Company lifted their price objective on shares of Hyperfine from $0.68 to $0.85 and gave the company an "equal weight" rating in a report on Friday, August 15th. Two analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $1.28.

Hyperfine Price Performance

The business has a 50-day moving average of $1.27 and a two-hundred day moving average of $0.92. The company has a market cap of $113.94 million, a P/E ratio of -2.79 and a beta of 1.07.

Hyperfine (NASDAQ:HYPR - Get Free Report) last issued its quarterly earnings data on Wednesday, August 13th. The company reported ($0.12) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.12). Hyperfine had a negative net margin of 364.54% and a negative return on equity of 84.82%. The firm had revenue of $2.70 million for the quarter, compared to the consensus estimate of $3.00 million. Hyperfine has set its FY 2025 guidance at EPS. Equities analysts anticipate that Hyperfine, Inc. will post -0.57 EPS for the current fiscal year.

Institutional Investors Weigh In On Hyperfine

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. EP Wealth Advisors LLC acquired a new position in shares of Hyperfine during the first quarter valued at about $25,000. Wealth Enhancement Advisory Services LLC grew its position in Hyperfine by 64.3% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 82,008 shares of the company's stock worth $72,000 after purchasing an additional 32,093 shares during the last quarter. Finally, AMH Equity Ltd acquired a new position in Hyperfine during the 1st quarter valued at approximately $90,000. 15.03% of the stock is currently owned by hedge funds and other institutional investors.

About Hyperfine

Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.